cached image

Amy H. Newman

Affiliations: 
Medicinal Chemistry National Institutes of Health, Bethesda, MD 
Area:
G-protein coupled receptors
Website:
http://irp.drugabuse.gov/Newman.php
Google:
"Amy H. Newman"
Bio:

http://www.chemheritage.org/discover/collections/oral-histories/details/newman-amy-h.aspx
http://www.chemheritage.org/discover/online-resources/women-in-chemistry/beyond-the-legend-of-marie-curie.aspx?page=3
http://www.chemheritage.org/Oral-Histories/Documents/A-Newman--Front-Matter-and-Index.pdf

Mean distance: 21.77
 
SNBCP
Cross-listing: Chemistry Tree

Parents

Sign in to add mentor
Richard A. Glennon grad student 1985 VCU (Chemistry Tree)
Kenner C. Rice post-doc 1985-1988 NIDDK, NIH

Children

Sign in to add trainee
Michael P. Ellenberger research assistant NIH (NIDA) (Chemistry Tree)
Thomas M. Keck post-doc 2009-2014 NIDA Intramural Research Program (Cell Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Giancola JB, Bonifazi A, Cao J, et al. (2020) Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability. European Journal of Medicinal Chemistry. 208: 112674
Jordan CJ, He Y, Bi GH, et al. (2020) (±)VK4-40, a Novel D R Partial Agonist, Attenuates Cocaine Reward and Relapse in Rodents. British Journal of Pharmacology
Mereu M, Hiranita T, Jordan CJ, et al. (2020) Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Slack RD, Ku T, Cao J, et al. (2019) Structure-Activity Relationships for a series of bis(4-fluorophenyl)methyl)sulfinyl)alkyl alicyclic amines at the dopamine transporter: functionalizing the terminal nitrogen affects affinity, selectivity and metabolic stability. Journal of Medicinal Chemistry
Jordan CJ, Cao J, Newman AH, et al. (2019) Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology
Jordan CJ, Humburg B, Rice M, et al. (2019) The highly selective dopamine DR antagonist, RVK4-40, attenuates oxycodone reward and augments analgesia in rodents. Neuropharmacology
Cai NS, Quiroz C, Bonaventura J, et al. (2019) Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. The Journal of Clinical Investigation. 130
Newman AH, Cao J, Keighron JD, et al. (2019) Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Keighron JD, Quarterman JC, Cao J, et al. (2019) Effects of R-Modafinil and Modafinil Analogs on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell. Acs Chemical Neuroscience
You ZB, Bi GH, Galaj E, et al. (2018) Dopamine DR antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
See more...